Hans Voshol

4.0k total citations
45 papers, 2.3k citations indexed

About

Hans Voshol is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Spectroscopy. According to data from OpenAlex, Hans Voshol has authored 45 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 10 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Spectroscopy. Recurrent topics in Hans Voshol's work include Glycosylation and Glycoproteins Research (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Advanced Proteomics Techniques and Applications (8 papers). Hans Voshol is often cited by papers focused on Glycosylation and Glycoproteins Research (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Advanced Proteomics Techniques and Applications (8 papers). Hans Voshol collaborates with scholars based in Switzerland, United States and Netherlands. Hans Voshol's co-authors include Jan van Oostrum, Sjouke Hoving, Johannes F.G. Vliegenthart, Patrick Schindler, Harry Towbin, Débora Bonenfant, Melitta Schachner, D. R. Müller, D. Müller and Michel O. Steinmetz and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Immunology.

In The Last Decade

Hans Voshol

45 papers receiving 2.3k citations

Peers

Hans Voshol
Steven H. Seeholzer United States
Tapasree Goswami United States
Francis Vilbois Switzerland
Ruedi H. Aebersold United States
Raghothama Chaerkady United States
Bo Zhai United States
Chong‐Feng Xu United States
Philip R. Gafken United States
Hans Voshol
Citations per year, relative to Hans Voshol Hans Voshol (= 1×) peers Stefan Müller

Countries citing papers authored by Hans Voshol

Since Specialization
Citations

This map shows the geographic impact of Hans Voshol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Voshol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Voshol more than expected).

Fields of papers citing papers by Hans Voshol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Voshol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Voshol. The network helps show where Hans Voshol may publish in the future.

Co-authorship network of co-authors of Hans Voshol

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Voshol. A scholar is included among the top collaborators of Hans Voshol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Voshol. Hans Voshol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Solovyeva, Elizaveta M., Erik Ahrné, E.A. Hermes, et al.. (2023). Integrative Proteogenomics for Differential Expression and Splicing Variation in a DM1 Mouse Model. Molecular & Cellular Proteomics. 23(1). 100683–100683. 2 indexed citations
2.
Bidinosti, Michael, Paolo Botta, Sebastian Krüttner, et al.. (2016). CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency. Science. 351(6278). 1199–1203. 115 indexed citations
3.
Leroy, Cédric, Pedro Marques Ramos, Karen Cornille, et al.. (2016). Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition. Breast Cancer Research. 18(1). 41–41. 60 indexed citations
4.
Sausgruber, Nina, Marie‐May Coissieux, Adrian Britschgi, et al.. (2014). Tyrosine phosphatase SHP2 increases cell motility in triple-negative breast cancer through the activation of SRC-family kinases. Oncogene. 34(17). 2272–2278. 54 indexed citations
5.
Alajati, Abdullah, Nina Sausgruber, Nicola Aceto, et al.. (2013). Mammary Tumor Formation and Metastasis Evoked by a HER2 Splice Variant. Cancer Research. 73(17). 5320–5327. 52 indexed citations
6.
Michaloglou, Chrysiis, Typhaine Martin, Clara Delaunay, et al.. (2013). The Tyrosine Phosphatase PTPN14 Is a Negative Regulator of YAP Activity. PLoS ONE. 8(4). e61916–e61916. 69 indexed citations
7.
Voshol, Hans, et al.. (2009). Antibody‐based proteomics. FEBS Journal. 276(23). 6871–6879. 45 indexed citations
8.
Plikat, Uwe, Hans Voshol, Brigitte Wiedmann, et al.. (2007). From proteomics to systems biology of bacterial pathogens: Approaches, tools, and applications. PROTEOMICS. 7(6). 992–1003. 15 indexed citations
9.
Mueller, Dieter, Hans Voshol, Annick Waldt, Brigitte Wiedmann, & Jan van Oostrum. (2007). LC-MALDI MS and MS/MS — An Efficient Tool in Proteome Analysis. Sub-cellular biochemistry. 43. 355–380. 26 indexed citations
10.
Fritsch, Christine, Katrina L. Schmid, P. Schmid, et al.. (2005). Ocular Axial Growth Control and Proteomics: Differential Protein Expression in an Experimental Animal Model. Investigative Ophthalmology & Visual Science. 46(13). 3331–3331. 1 indexed citations
11.
Freitas, Fernanda Zanolli, Marc G. Jeschke, Ivana Majstorović, et al.. (2002). Fluoroaluminate stimulates phosphorylation of p130 Cas and Fak and increases attachment and spreading of preosteoblastic MC3T3-E1 cells. Bone. 30(1). 99–108. 25 indexed citations
12.
Gutiérrez–Gallego, Ricardo, José L. Jiménez Blanco, Charlotte H. Gotfredsen, et al.. (2001). Epitope Diversity of N-Glycans from Bovine Peripheral Myelin Glycoprotein P0 Revealed by Mass Spectrometry and Nano Probe Magic Angle Spinning 1H NMR Spectroscopy. Journal of Biological Chemistry. 276(33). 30834–30844. 42 indexed citations
13.
Steinmetz, Michel O., Wolfgang Jahnke, Harry Towbin, et al.. (2001). Phosphorylation disrupts the central helix in Op18/stathmin and suppresses binding to tubulin. EMBO Reports. 2(6). 505–510. 47 indexed citations
14.
Geiser, Martin, et al.. (1999). Identification of the human melanoma-associated chondroitin sulfate proteoglycan antigen epitope recognized by the antitumor monoclonal antibody 763.74 from a peptide phage library.. PubMed. 59(4). 905–10. 10 indexed citations
15.
Müller, D. R., Patrick Schindler, M. Coulot, Hans Voshol, & Jan van Oostrum. (1999). Mass spectrometric characterization of stathmin isoforms separated by 2D PAGE. Journal of Mass Spectrometry. 34(4). 336–345. 34 indexed citations
16.
Voshol, Hans, et al.. (1996). Structure of the HNK-1 Carbohydrate Epitope on Bovine Peripheral Myelin Glycoprotein P0. Journal of Biological Chemistry. 271(38). 22957–22960. 137 indexed citations
17.
Voshol, Hans, Hub F. J. Dullens, Willem Den Otter, & Johannes F.G. Vliegenthart. (1996). The glycosylation profile of interleukin-2 activated human lymphocytes correlates to their anti-tumor activity.. PubMed. 16(1). 155–9. 3 indexed citations
18.
Voshol, Hans, Hub F. J. Dullens, Willem Den Otter, & Johannes F.G. Vliegenthart. (1993). Human natural killer cells: a convenient purification procedure and the influence of cryopreservation on cytotoxic activity. Journal of Immunological Methods. 165(1). 21–30. 31 indexed citations
19.
Horst, Dick J. Van der, J.M. Van Doorn, Hans Voshol, et al.. (1991). Different isoforms of an apoprotein (apolipophorin III) associate with lipoproteins in Locusta migratoria. European Journal of Biochemistry. 196(2). 509–517. 35 indexed citations
20.
DAMM, Jan B. L., Hans Voshol, Karl Hård, Johannis P. Kamerling, & Johannes F.G. Vliegenthart. (1989). Analysis of N‐acetyl‐4‐O‐acetylneuraminic‐acid‐containing. N‐linked carbohydrate chains released by peptide‐N4‐(N‐acetyl‐β‐glucosaminyl)asparagine amidase F. European Journal of Biochemistry. 180(1). 101–110. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026